Emmaus Life Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $-1.1M | $988.1K |
| FY2010 | — | $-4.2M | $55.4K |
| FY2011 | — | $-11.4M | $73.6K |
| FY2012 | — | $-13.1M | $7.7K |
| FY2013 | — | $-2.2M | $1.3M |
| FY2014 | — | $-1.8M | $1.2M |
| FY2015 | — | $-4.8M | $432.1K |
| FY2016 | — | $-1.1M | $318.2K |
| FY2017 | — | $4.5M | $5.4M |
| FY2018 | $587.7K | $4.0M | $3.3M |
| FY2019 | — | $-12.2M | $1.3M |
| FY2020 | $15.3M | $-5.2M | $2.5M |
| FY2021 | $22.3M | $-21.5M | $2.3M |
| FY2022 | $30.4M | $-34.1M | $2.0M |
| FY2023 | $30.6M | $-47.8M | $2.5M |
| FY2024 | $29.0M | $-56.5M | $1.4M |
| FY2025 | $27.1M | $-63.6M | $2.1M |